港股早評:恆指低開0.9% 科技股下挫 生物醫藥股表現強勢
格隆匯2月21日丨俄烏緊張局勢攪動市場,港股大幅低開,恆指跌0.9%,國指跌1.01%,恆生科技指數跌1.53%。盤面上,大型科技股普跌,美團跌超5%,百度、阿里巴巴跌超3%,百度、騰訊、小米皆下跌;藥品股、汽車股跌幅靠前,在線教育股、餐飲股、體育用品股、內房股紛紛走低;另一方面,生物科技B類股走強,康希諾生物大漲近9%表現最佳,獲納入恆生指數,聯想集團、農夫山泉皆高開。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.